vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Comstock Holding Companies, Inc. (CHCI). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $23.9M, roughly 1.0× Comstock Holding Companies, Inc.). Comstock Holding Companies, Inc. runs the higher net margin — 56.3% vs -54.6%, a 110.9% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

The Comstock Lode is a lode of silver ore located under the eastern slope of Mount Davidson, a peak in the Virginia Range in Virginia City, Nevada, which was the first major discovery of silver ore in the United States and named after Canadian miner Henry Comstock.

CBLL vs CHCI — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.0× larger
CBLL
$24.8M
$23.9M
CHCI
Higher net margin
CHCI
CHCI
110.9% more per $
CHCI
56.3%
-54.6%
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
CHCI
CHCI
Revenue
$24.8M
$23.9M
Net Profit
$-13.5M
$13.5M
Gross Margin
87.3%
35.5%
Operating Margin
-58.9%
32.4%
Net Margin
-54.6%
56.3%
Revenue YoY
41.5%
Net Profit YoY
30.5%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
CHCI
CHCI
Q4 25
$24.8M
$23.9M
Q3 25
$22.6M
$13.3M
Q2 25
$21.2M
$13.0M
Q1 25
$20.5M
$12.6M
Q4 24
$16.9M
Q3 24
$17.2M
$13.0M
Q2 24
$10.8M
Q1 24
$10.6M
Net Profit
CBLL
CBLL
CHCI
CHCI
Q4 25
$-13.5M
$13.5M
Q3 25
$-13.5M
$541.0K
Q2 25
$-13.6M
$1.4M
Q1 25
$-12.8M
$1.6M
Q4 24
$10.3M
Q3 24
$-10.4M
$2.4M
Q2 24
$946.0K
Q1 24
$910.0K
Gross Margin
CBLL
CBLL
CHCI
CHCI
Q4 25
87.3%
35.5%
Q3 25
88.3%
11.0%
Q2 25
88.1%
19.0%
Q1 25
87.9%
18.6%
Q4 24
33.4%
Q3 24
87.3%
26.3%
Q2 24
17.2%
Q1 24
16.5%
Operating Margin
CBLL
CBLL
CHCI
CHCI
Q4 25
-58.9%
32.4%
Q3 25
-64.8%
5.0%
Q2 25
-70.5%
13.7%
Q1 25
-69.3%
13.7%
Q4 24
30.1%
Q3 24
-57.8%
21.8%
Q2 24
11.4%
Q1 24
10.8%
Net Margin
CBLL
CBLL
CHCI
CHCI
Q4 25
-54.6%
56.3%
Q3 25
-59.6%
4.1%
Q2 25
-64.4%
11.1%
Q1 25
-62.4%
12.6%
Q4 24
61.1%
Q3 24
-60.6%
18.3%
Q2 24
8.8%
Q1 24
8.6%
EPS (diluted)
CBLL
CBLL
CHCI
CHCI
Q4 25
$-0.35
Q3 25
$-0.37
Q2 25
$-0.38
Q1 25
$-0.36
Q4 24
Q3 24
$-1.85
Q2 24
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
CHCI
CHCI
Cash + ST InvestmentsLiquidity on hand
$159.3M
$31.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$70.0M
Total Assets
$195.8M
$85.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
CHCI
CHCI
Q4 25
$159.3M
$31.3M
Q3 25
$168.5M
$26.2M
Q2 25
$177.4M
$30.5M
Q1 25
$182.7M
$28.3M
Q4 24
$28.8M
Q3 24
$14.1M
$21.1M
Q2 24
$17.4M
Q1 24
$16.2M
Stockholders' Equity
CBLL
CBLL
CHCI
CHCI
Q4 25
$155.3M
$70.0M
Q3 25
$164.1M
$56.3M
Q2 25
$172.2M
$55.5M
Q1 25
$180.9M
$53.7M
Q4 24
$52.4M
Q3 24
$-136.0M
$41.7M
Q2 24
$39.2M
Q1 24
$37.9M
Total Assets
CBLL
CBLL
CHCI
CHCI
Q4 25
$195.8M
$85.0M
Q3 25
$199.5M
$67.6M
Q2 25
$207.7M
$65.2M
Q1 25
$213.5M
$62.8M
Q4 24
$64.9M
Q3 24
$47.1M
$52.2M
Q2 24
$48.6M
Q1 24
$46.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
CHCI
CHCI
Operating Cash FlowLast quarter
$-10.8M
$4.8M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
CHCI
CHCI
Q4 25
$-10.8M
$4.8M
Q3 25
$-11.1M
$-3.2M
Q2 25
$-7.5M
$2.2M
Q1 25
$-11.4M
$582.0K
Q4 24
$10.7M
Q3 24
$3.9M
Q2 24
$1.3M
Q1 24
$-2.2M
Free Cash Flow
CBLL
CBLL
CHCI
CHCI
Q4 25
$-11.0M
Q3 25
$-11.5M
Q2 25
$-7.6M
Q1 25
$-11.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CBLL
CBLL
CHCI
CHCI
Q4 25
-44.2%
Q3 25
-50.8%
Q2 25
-35.9%
Q1 25
-56.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CBLL
CBLL
CHCI
CHCI
Q4 25
0.7%
Q3 25
1.6%
Q2 25
0.3%
Q1 25
0.7%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
CBLL
CBLL
CHCI
CHCI
Q4 25
0.36×
Q3 25
-5.96×
Q2 25
1.51×
Q1 25
0.37×
Q4 24
1.03×
Q3 24
1.63×
Q2 24
1.35×
Q1 24
-2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

CHCI
CHCI

Related Party$22.1M92%
Nonrelated Party$1.9M8%

Related Comparisons